GRADE guidelines: 7. Rating the quality of evidence-inconsistency

Chinese Journal of Evidence-Based Medicine

Volumn 11, Issue 12, 2011, Pages 1444-1451

  Guyatt, Gordon H ^a   Oxman, Andrew D ^a   Kunz, Regina ^a   Woodcock, James ^a   Brozek, Jan ^a   Helfand, Mark ^a   Alonso Coello, Pablo ^a   Glasziou, Paul ^a   Jaeschke, Roman ^a   Akl, Elie A ^a   Norris, Susan ^a   Vist, Gunn ^a   Dahm, Philipp ^a   Shukla, Vijay K ^a   Higgins, Julian ^a   Falck Ytter, Yngve ^a   Schünemann, Holger J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856749607     PISSN: 16722531     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Furukawa TA, Guyatt GH, Griffith LE. Can we individualize the "number needed to treat"? An empirical study of summary effect measures in meta-analyses. Int J Epidemiol, 2002, 31(1): 72-76.
2. Deeks JJ. Issues in the selection of a summary statistic for metaanalysis of clinical trials with binary outcomes. Stat Med, 2002, 21: 1575-1600.
3. Schmid CH, Lau J, McIntosh MW, et al. An empirical study of the effect of the control rate as a predictor of treatment efficacy in metaanalysis of clinical trials. Stat Med, 1998, 17: 1923-1942.
4. Guyatt G, Oxman AD, Kunz R, et al. Grade guidelines: 2. Framing the question. J Clin Epidemiol, 2011, 64: 395-400.
5. Guyatt G, Oxman A, Vist G, et al. Grade guidelines: 12. Preparing summary of findings tables. J Clin Epidemiol [in press].
6. Balshem H, Helfand M, Sch€unemann HJ, et al. Grade guidelines: 3 Rating the quality of evidenced introduction. J Clin Epidemiol, 2011, 64: 401-406.
7. Guyatt G, Jaeschke R, Prasad K, et al. Summarizing the evidence. In: Guyatt G, Rennie D, Meade M, Cook D, editors. The users'guides to the medical literature: a manual for evidence-based clinical practice. New York, NY: McGraw-Hill; 2008.
8. Deeks J, Higgins J, Altman D. Analyzing data and undertaking meta-analyses. In: Higgins J, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.0.0. Chichester: Wiley; 2008.
9. Rucker G, Schwarzer G, Carpenter JR, et al. Undue reliance on I(2) in assessing heterogeneity may mislead. BMC Med Res Methodol, 2008, 8: 79.
10. Juni P, Nartey L, Reichenbach S, et al. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet, 2004, 364(9450): 2021-2029.
11. Guyatt G, Devereaux PJ, Lexchin J, et al. A systematic review of studies comparing health outcomes in Canada and the United States. OpenMed, 2007, 1(1): e27-36.
12. Alonso-Coello P, Zhou Q, Martinez-Zapata MJ, et al. Meta-analysis of flavonoids for the treatment of haemorrhoids. Br J Surg, 2006, 93: 909-920.
13. Tang BM, Eslick GD, Nowson C, et al. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet, 2007, 370(9588): 657-666.
14. Guyatt G, Wyer P, Ioannidis J. When to believe a subgroup analysis. In: Guyatt G, et al, editors. The users' guides to the medical literature: a manual for evidence-based clinical practice. New York, NY: McGraw-Hill; 2008.
15. Oxman AD, Cook DJ, Guyatt GH. Users' guides to the medical literature.VI. How to use an overview. Evidence-Based Medicine Working Group. JAMA, 1994, 272(17): 1367-1371.
16. Sun X, Briel M, Walter SD, et al. Is a subgroup effect believable? Updating criteria to evaluate the credibility of subgroup analyses. BMJ, 2010, 340: c117.
17. Briel M, Meade M, Mercat A, et al. Higher vs lower positive endexpiratory pressure in patients with acute lung injury and acute respiratory distress syndrome: systematic review and meta-analysis. JAMA, 2010, 303(9): 865-873.
18. Wyer PC, Perera P, Jin Z, et al. Vasopressin or epinephrine for outof-hospital cardiac arrest. Ann Emerg Med, 2006, 48(1): 86-97.
19. Wenzel V, Krismer AC, Arntz HR, et al. A comparison of vasopressin and epinephrine for out-of-hospital cardiopulmonary resuscitation. N Engl J Med, 2004, 350(2): 105-113.